Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Núria Reig

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
FEBS Letters|September 12, 2006
About lipids and toxinsNúria Reig, F Gisou van der Goot
Seminars in Immunopathology|September 7, 2007
The role of the inflammasome in cellular responses to toxins and bacterial effectorsBarbara Freche, Núria Reig, F Gisou van der Goot
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 24, 2019
Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study<sup></sup>Josep Gamez, María Salvadó, Núria Reig, et al.
The EMBO Journal|September 18, 2002
The light subunit of system b(o,+) is fully functional in the absence of the heavy subunitNúria Reig, Josep Chillarón, Paola Bartoccioni, et al.
International Journal of Molecular Sciences|June 24, 2022
A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) InhibitorsSeri Jo, Luca Signorile, Suwon Kim, et al.
Cellular Microbiology|January 16, 2008
Maturation modulates caspase-1-independent responses of dendritic cells to Anthrax lethal toxinNúria Reig, Aimin Jiang, Rachael Couture, et al.
British Journal of Clinical Pharmacology|December 9, 2022
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's diseaseJosep Gamez, Matilde Calopa, Esteban Muñoz, et al.
The Journal of Biological Chemistry|March 9, 2007
Functional and structural characterization of the first prokaryotic member of the L-amino acid transporter (LAT) family: a model for APC transportersNúria Reig, César del Rio, Fabio Casagrande, et al.
Nature Communications|February 24, 2016
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicityRicardo Sant'Anna, Pablo Gallego, Lei Z Robinson, et al.
Nature Communications|February 3, 2023
Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicityRicardo Sant'Anna, Pablo Gallego, Lei Z Robinson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
FEBS Letters|September 12, 2006
About lipids and toxinsNúria Reig, F Gisou van der Goot
Seminars in Immunopathology|September 7, 2007
The role of the inflammasome in cellular responses to toxins and bacterial effectorsBarbara Freche, Núria Reig, F Gisou van der Goot
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 24, 2019
Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study<sup></sup>Josep Gamez, María Salvadó, Núria Reig, et al.
The EMBO Journal|September 18, 2002
The light subunit of system b(o,+) is fully functional in the absence of the heavy subunitNúria Reig, Josep Chillarón, Paola Bartoccioni, et al.
International Journal of Molecular Sciences|June 24, 2022
A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) InhibitorsSeri Jo, Luca Signorile, Suwon Kim, et al.
Cellular Microbiology|January 16, 2008
Maturation modulates caspase-1-independent responses of dendritic cells to Anthrax lethal toxinNúria Reig, Aimin Jiang, Rachael Couture, et al.
British Journal of Clinical Pharmacology|December 9, 2022
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's diseaseJosep Gamez, Matilde Calopa, Esteban Muñoz, et al.
The Journal of Biological Chemistry|March 9, 2007
Functional and structural characterization of the first prokaryotic member of the L-amino acid transporter (LAT) family: a model for APC transportersNúria Reig, César del Rio, Fabio Casagrande, et al.
Nature Communications|February 24, 2016
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicityRicardo Sant'Anna, Pablo Gallego, Lei Z Robinson, et al.
Nature Communications|February 3, 2023
Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicityRicardo Sant'Anna, Pablo Gallego, Lei Z Robinson, et al.
Pageof 1